INMD250117P16000
- 0.19
- -0.06-24.00%
InMode Newsroom
With 57% Institutional Ownership, InMode Ltd. (NASDAQ:INMD) Is a Favorite Amongst the Big Guns
Is There An Opportunity With InMode Ltd.'s (NASDAQ:INMD) 49% Undervaluation?
Why Is InMode Ltd. (INMD) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
InMode Completes Repayment of Silicon Valley Bank Debt
Dr. Luis Macias and Aesthetic MdR Host Esteemed International Visiting Professor Dr. Francisco Gomez Bravo at USC Plastic Surgery
The Returns On Capital At InMode (NASDAQ:INMD) Don't Inspire Confidence
InMode's (NASDAQ:INMD) Earnings Have Declined Over Three Years, Contributing to Shareholders 77% Loss
InMode (NASDAQ:INMD) Might Be Having Difficulty Using Its Capital Effectively
InMode to Present at Upcoming Investor Conferences
We Think You Can Look Beyond InMode's (NASDAQ:INMD) Lackluster Earnings
UBS Adjusts Price Target on InMode to $19 From $17, Maintains Neutral Rating
InMode Analyst Ratings
Needham Maintains InMode(INMD.US) With Hold Rating
Hartwater Aesthetics CEO to Deliver Keynote Address at Upcoming Industry Conference
InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript Summary
InMode's Q3 Non-GAAP Earnings, Revenue Increase; Lowers 2024 Revenue Outlook
Express News | Inmode Ltd: Full-Year 2024 Revenue Guidance Has Been Revised to Be Between $410 Mln and $420 Mln
InMode Cuts FY24 View To Rev $410M-$420M >INMD
InMode: Q3 Earnings Snapshot
Earnings Flash (INMD) INMODE Posts Q3 EPS $0.70